Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Royalty Pharma (NASDAQ:RPRX) has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company will engage in a fireside chat on Tuesday, September 9, 2025, at 3:20 p.m. ET. Investors can access the webcast through Royalty Pharma's "Events" page on their investor relations website, where it will remain archived for at least thirty days.
Royalty Pharma (NASDAQ:RPRX) ha confermato la sua partecipazione alla 23ª Morgan Stanley Annual Global Healthcare Conference. L'azienda terrà una fireside chat martedì 9 settembre 2025 alle 15:20 ET. Gli investitori potranno seguire la webcasting dalla pagina «Eventi» del sito investor relations di Royalty Pharma, dove sarà archiviato per almeno trenta giorni.
Royalty Pharma (NASDAQ:RPRX) ha anunciado su participación en la 23.ª Morgan Stanley Annual Global Healthcare Conference. La compañía participará en una charla informal (fireside chat) el martes 9 de septiembre de 2025 a las 3:20 p.m. ET. Los inversores podrán acceder a la retransmisión desde la página «Events» del sitio de relaciones con inversores de Royalty Pharma, donde permanecerá archivada durante al menos treinta días.
Royalty Pharma (NASDAQ:RPRX)는 Morgan Stanley 제23회 연례 글로벌 헬스케어 콘퍼런스에 참여한다고 발표했습니다. 회사는 2025년 9월 9일 화요일 동부 표준시 기준 오후 3시 20분에 파이어사이드 채팅을 진행합니다. 투자자들은 Royalty Pharma 투자자 관계 웹사이트의 “Events” 페이지에서 웹캐스트를 시청할 수 있으며, 해당 영상은 최소 30일간 보관됩니다.
Royalty Pharma (NASDAQ:RPRX) a annoncé sa participation à la 23e Morgan Stanley Annual Global Healthcare Conference. La société tiendra un fireside chat le mardi 9 septembre 2025 à 15h20 ET. Les investisseurs pourront accéder au webcast via la page « Events » du site relations investisseurs de Royalty Pharma, où il restera archivé pendant au moins trente jours.
Royalty Pharma (NASDAQ:RPRX) hat seine Teilnahme an der 23. Morgan Stanley Annual Global Healthcare Conference angekündigt. Das Unternehmen wird an einem Fireside Chat am Dienstag, den 9. September 2025, um 15:20 Uhr ET teilnehmen. Investoren können das Webcast über die „Events“-Seite auf der Investor-Relations-Website von Royalty Pharma aufrufen; die Aufzeichnung wird dort mindestens dreißig Tage verfügbar sein.
- None.
- None.
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025 at 3:20 p.m. ET.
The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap="/articles/market-capitalization-explained" title="Read: What Is Market Capitalization and How It Is Calculated" class="article-link" rel="noopener">mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, Servier’s Voranigo, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Pfizer’s Nurtec ODT, and Gilead’s Trodelvy, and 17 development-stage product candidates. For more information, visit www.royaltypharma.com.
Royalty Pharma Investor Relations and Communications
+1 (212) 883-6637
ir@royaltypharma.com
FAQ
When is Royalty Pharma (RPRX) presenting at the Morgan Stanley Healthcare Conference 2025?
How can investors watch Royalty Pharma's Morgan Stanley conference presentation?
How long will Royalty Pharma's Morgan Stanley conference presentation be available online?
What type of presentation will RPRX give at the Morgan Stanley Healthcare Conference?
